Oligomerix
Biotechnology, Ediscovery, Medical
Founded in 1/1/06
Bronx, New York, United States
For Profit
About Oligomerix
Oligomerix is a biopharmaceutical company founded in 2006 by co-founders Eliot J. Davidowitz and James Moe. The Company is exploiting its novel research that allows rapid generation of stable amyloid oligomers as targets for drug discovery. These systems will enable target identification and validation, and drug discovery for Alzheimer's and other neurodegenerative diseases.
Company Metrics
- Employees: 1-10
- Monthly Visits: 8014
- Tech Stack: 12 active products
Financial Information
- Estimated Revenue: Less than $1M
- Total Funding: 17620000 USD
- Last Funding: 2490000 USD (Grant)
- Funding Status: Early Stage Venture
Technology Stack
Oligomerix actively uses 12 products in their tech stack.
Market Presence
Industries: Biotechnology, Ediscovery, Medical
Headquarters: Bronx, New York, United States
Leadership
Employees
- Bob Foerster - Chief Financial Officer / Chief Operations Officer (LinkedIn)